Table 2.
Nanoparticles used as anticancer drug delivery vehicles, their respective parameters, and their corresponding visual PROMETHEE values.
Criteria | BC | ACC | TO | SP | ST | EF | AE | SA |
Unit | % | % | % | % | % | % | % | % |
| ||||||||
Preference | ||||||||
Max\min | Max | Min | Min | Max | Max | Max | Min | Max |
Weight | VH | VH | VH | H | H | VH | VH | VH |
Preference fn. | Gaussian | Gaussian | Gaussian | Gaussian | Gaussian | Gaussian | Gaussian | Gaussian |
| ||||||||
Evaluation | ||||||||
AuNPs | VH | VL | VL | VH | VH | VH | VL | VH |
Liposomes | H | H | H | H | H | H | L | L |
Dendrimers | M | H | M | M | M | M | M | M |
PMs | H | M | M | H | H | VH | L | H |
QDs | M | H | L | H | M | H | H | VL |
∗AuNPs: gold nanoparticles; PMs: polymeric micelles; QDs: quantum dots; BC: biocompatibility; ACC: accumulation rate; TO: toxicity; SP: specificity; ST: stability; EF: efficacy; AE: adverse effect; SA: safety; H: high; M: medium; VH: very high; L: low; VL: very low; A: average; G: good; VG: very good.